Epitope mapping of four novel CD44 monoclonal antibodies using surface plasmon resonance and soluble CD44

CD44 is a ubiquitous multistructural and multifunctional cell surface adhesion molecule. The molecular diversity of this glycoprotein is generated by both post‐translational modification and the differential use of alternatively spliced exons which play a critical role in determining the exact conformation of the molecule. CD44 isoforms are found in many tissues and in soluble form in plasma. Soluble CD44 was purified by a two‐step purification combining ion exchange and immuno‐affinity chromatography. Our aim was to check that all the known antigenic epitopes are present on sCD44, which could thus be used for the mapping of new anti‐CD44 antibodies. Competitive binding assays using reference antibodies and novel anti‐CD44 monoclonal antibodies were performed by real‐time biospecific interaction analysis. Reference mAbs identified on soluble CD44 the three distinct epitopes previously defined using red blood cell membrane CD44. From the four novel CD44 mAbs, two mAbs (NaM198‐6B5, NaM198‐10B4) mapped to epitope group 1, whereas the others (NaM10‐8F4, NaM77‐9D6) mapped to epitope group 2. Immunopurified sCD44 obtained from the plasma of healthy donors appears to be a usable tool for the mapping of anti‐CD44 mAbs.